Preclinical insights into the implementation of intrathepal midazolam: A cautionary tale

Anesthesia and Analgesia

Volumn 98, Issue 6, 2004, Pages 1509-1511

  Yaksh, Tony L ^a   Allen, Jeffrey W ^a  

^a University of California   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FENTANYL DERIVATIVE; LOCAL ANESTHETIC AGENT; MIDAZOLAM; MORPHINE;

BEHAVIOR; DRUG SAFETY; EDITORIAL; HUMAN; LABOR; NERVE FUNCTION; PRIORITY JOURNAL; SPASTICITY; SPINAL ANESTHESIA;

EID: 2442709260     PISSN: 00032999     EISSN: None     Source Type: Journal    
DOI: 10.1213/01.ANE.0000121768.79904.7F     Document Type: Editorial

References (21)

1. Johansen MJ, Gradert TL, Satterfield WC, et al. Safety and efficacy of continuous intrathecal midazolam infusion in the sheep model. Anesth Analg 2004;98:1528-35.
2. Tucker AP, Lai C, Nadeson R, Goodchild CS. Intrathecal midazolam. I. A cohort study investigating safety. Anesth Analg 2004;98:1512-20.
3. Tucker AP, Mezzatesta J, Nadeson R, Goodchild CS. Intrathecal midazolam. II. Combination with intrathecal fentanyl for labour pain. Anesth Analg 2004;98:1521-7.
4. Yaksh TL, Allen JW. The use of intrathecal midazolam in humans: a case study of process. Anesth Analg 2004;98: 1536-45.
5. Yaksh TL. Spinal systems and pain processing: development of novel analgesic drugs with mechanistically defined models. Trends Pharmacol Sci 1999;20:329-37.
6. Yaksh TL, Rathbun ML, Provencher JC. Preclinical safety evaluation for spinal drugs. In: Yaksh TL, ed. Spinal drug delivery. Amsterdam: Elsevier Science B.V., 1999:417-37.
7. Abouleish E, Barmada MA, Nemoto EM, et al. Acute and chronic effects of intrathecal morphine in monkeys. Br J Anaesth 1981;53:1027-32.
8. Yaksh TL, Noueihed RY, Durant PAC. Studies of the pharmacology and pathology of intrathecally administered 4-anilinopiperidine analogues and morphine in rat and cat. Anesthesiology 1986;64:54-66.
9. Sabbe MB, Grafe MR, Mjanger E, et al. Spinal delivery of sufentanil, alfentanil and morphine in dogs: physiologic and toxicologic investigations. Anesthesiology 1994;81:899-920.
10. Muller H, Gerlach H, Boldt J, et al. Spasticity treatment with spinal morphine or midazolam: in vitro experiments, animal studies and clinical studies on compatibility and effectiveness. Anaesthesist 1986;35:306-16.
11. Goodchild CS, Noble J. The effects of intrathecal midazolam on sympathetic nervous system reflexes in man: a pilot study. Br J Clin Pharmacol 1987;23:279-85.
12. Whitwam JG, Niv D, Loh L, Jack RD. Depression of nociceptive reflexes by intrathecal benzodiazepine in dogs. Lancet 1982;2: 1465.
13. Malinovsky JM, Cozian A, Lepage JY, et al. Ketamine and midazolam neurotoxicity in the rabbit. Anesthesiology 1991;75: 91-7.
14. Bahar M, Cohen ML, Grinshpon Y, Chanimov M. Spinal anaesthesia with midazolam in the rat. Can J Anaesth 1997;44:208-15.
15. Erdine S, Yucel A, Ozyalcin S, et al. Neurotoxicity of midazolam in the rabbit. Pain 1999;80:419-23.
16. Gradert TL, Baze WB, Satterfield WC, et al. Safety of chronic intrathecal morphine infusion in a sheep model. Anesthesiology 2003;99:188-98.
17. Malinovsky JM. Is intrathecal midazolam safe? Can J Anaesth 1997;44:1321-2.
18. Johnson ME. Potential neurotoxicity of spinal anesthesia with lidocaine. Mayo Clin Proc 2000;75:921-32.
19. Yaksh TL, Hassenbusch S, Burchiel K, et al. Inflammatory masses associated with intrathecal drug infusion: a review of preclinical evidence and human data. Pain Med 2002;3:300-12.
20. Follett KA. Intrathecal analgesia and catheter-tip inflammatory masses. Anesthesiology (Editorial Views) 2003;99:5-6.
21. Eisenach JC, Yaksh TL. Safety in numbers: how do we study toxicity of spinal analgesics? Anesthesiology 2002;97:1047-9.